Citation: | Xiaoyan WANG, Hua XIAO, Jiuhong GUO, Xiaofeng TAO. Application value of magnetic resonance imaging in patients with apical hypertrophy cardiomyopathy[J]. Journal of Molecular Imaging, 2019, 42(1): 1-4. doi: 10.12122/j.issn.1674-4500.2019.01.01 |
[1] |
Jan MF, Todaro MC, Oreto L, et al. Apical hypertrophic cardiomyopathy: Present status[J]. Int J Cardiol, 2016, 222(8): 745-59
|
[2] |
Yan LR, Wang ZM, Xu ZM, et al. Two hundred eight patients with apical hypertrophic cardiomyopathy in China: clinical feature, prognosis, and comparison of pure and mixed forms[J]. Clin Cardiol, 2012, 35(2): 101-6 doi: 10.1002/clc.20995
|
[3] |
冉玲平, 黄 璐, 赵培君, 等. RSNA2016心脏MRI/CT[J]. 放射学实践, 2017, 32(1): 3-7
|
[4] |
Maron MS. Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy[J]. J Cardiovasc Magn Reson, 2012, 14(1): 13-33 doi: 10.1186/1532-429X-14-13
|
[5] |
Kim EK, Lee SC, Hwang JW, et al. Differences in apical and non-apical types of hypertrophic cardiomyopathy: a prospective analysis of clinical, echocardiographic, and cardiac magnetic resonance findings and outcome from 350 patients[J]. Eur Heart J Cardiovasc Imaging, 2016, 17(6): 678-86 doi: 10.1093/ehjci/jev192
|
[6] |
Kebed KY, Al Adham RI, Bishu K, et al. Evaluation of apical subtype of hypertrophic cardiomyopathy using cardiac magnetic resonance imaging with Gadolinium enhancement[J]. Am J Cardiol, 2014, 114(5): 777-82 doi: 10.1016/j.amjcard.2014.05.067
|
[7] |
马晓海, 赵 蕾, 葛海龙, 等. 非对称性肥厚型心肌病与心尖肥厚型心肌病心脏磁共振成像特点分析[J]. 中国全科医学, 2015, 18(18): 2166-9 doi: 10.3969/j.issn.1007-9572.2015.18.011
|
[8] |
袁思殊, 李志伟, 夏黎明. 心尖肥厚型心肌病的MRI与超声心动图对比研究[J]. 磁共振成像, 2015, 6(3): 187-93 doi: 10.3969/j.issn.1674-8034.2015.03.006
|
[9] |
刘 洪, 余建群, 彭礼清. 磁共振延迟强化在肥厚型心肌病中的临床应用价值研究[J]. 放射学实践, 2017, 32(12): 1271-6
|
[10] |
刘东婷, 马晓海, 赵 蕾, 等. 钆布醇在磁共振延迟增强成像诊断肥厚型心肌病中的应用[J]. 中国医学影像学杂志, 2016, 24(5): 337-41 doi: 10.3969/j.issn.1005-5185.2016.05.005
|
[11] |
Kherada N, Vinardell JM, Mihos CG. Apical hypertrophic cardiomyopathy with left ventricular apical aneurysm: Importance of multi-modality imaging[J]. Echocardiography, 2017, 34(9): 1392-5 doi: 10.1111/echo.13581
|
[12] |
Fattori R, Biagini E, Lorenzini MA, et al. Significance of magnetic resonance imaging in apical hypertrophic cardiomyopathy[J]. Am J Cardiol, 2010, 105(11): 1592-6 doi: 10.1016/j.amjcard.2010.01.020
|
[13] |
Rosario, Parisi, Francesca, et al. Multimodality imaging in apical hypertrophic cardiomyopathy[J]. World J Cardiol, 2014, 6(9): 916-23 doi: 10.4330/wjc.v6.i9.916
|
[14] |
Doctorian T, Mosley WJ, Do B. Apical hypertrophic cardiomyopathy: case report and literature review[J]. Am J Case Rep, 2017, 18(6): 525-8
|
[15] |
Alvarez P, Tang WH. Recent advances in understanding and managing cardiomyopathy[J]. Res, 2017, 9(7): 1659-64
|
[16] |
Chan RH, Maron BJ, Olivotto I, et al. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy[J]. Circulation, 2014, 130(6): 484-95 doi: 10.1161/CIRCULATIONAHA.113.007094
|
[17] |
Shah M. Hypertrophic cardiomyopathy[J]. Cardiol Young, 2017, 27(S1): S25-30 doi: 10.1017/S1047951116002195
|
[18] |
Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J]. Circulation, 2011, 124(24): e783-831
|
[19] |
Rowin EJ, Maron BJ, Haas TS, et al. Hypertrophic cardiomyopathy with left ventricular apical aneurysm: implications for risk stratification and management t[J]. J Am Coll Cardio, 2017, 69(7): 761-73 doi: 10.1016/j.jacc.2016.11.063
|
[20] |
Dominguez F, Sanz J, Garcia P, et al. Follow-up and prognosis of HCM[J]. Glob Cardiol Sci Pract, 2018, 8(3): 33-8
|
[21] |
Reichek N. Imaging cardiac morphology in hypertrophic cardiomyopathy: recent advances[J]. Curr Opin Cardiol, 2015, 30(5): 461-7 doi: 10.1097/HCO.0000000000000209
|